...
首页> 外文期刊>Critical reviews in oncology/hematology >Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells.
【24h】

Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells.

机译:骨髓来源的细胞与肿瘤的生长:骨髓来源的细胞对肿瘤微环境的贡献,特别关注间充质干细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

Research has provided evidence that tumor growth depends on the interaction of tumor cells with stromal cells, as already suggested in 1889 by Paget. Experimental and clinical studies have revealed that tumor stromal cells can be derived from bone marrow (BM)-derived progenitor cells, such as mesenchymal stem cells (MSCs), which can be mobilized into the circulation and incorporate into tumor micro-environments. Many observations indicate that, in the tumor micro-environment, MSCs have several tumor growth promoting functions, including expression of growth factors, promotion of tumor vessel formation and creation of tumor stem cell niches. This review will discuss the currently known tumor growth promoting BM-derived cells and focus on the role of MSCs in modulating tumor micro-environments. In addition, we will discuss the potential of inhibiting BM-derived cells and their utilization as cellular vehicles for selective delivery of cancer therapeutics as additional strategies in the treatment of cancer.
机译:研究提供了证据,表明肿瘤的生长取决于肿瘤细胞与基质细胞的相互作用,正如Paget在1889年所提出的那样。实验和临床研究表明,肿瘤基质细胞可以衍生自骨髓(BM)衍生的祖细胞,例如间充质干细胞(MSCs),它们可以动员到循环系统中并整合到肿瘤微环境中。许多观察结果表明,在肿瘤微环境中,MSC具有多种促进肿瘤生长的功能,包括生长因子的表达,肿瘤血管形成的促进和肿瘤干细胞壁ches的形成。这篇综述将讨论当前已知的促进肿瘤生长的BM衍生细胞,并将重点放在MSC在调节肿瘤微环境中的作用。此外,我们将讨论抑制BM衍生细胞的潜力及其作为细胞载体用于选择性递送癌症治疗剂的可能性,作为治疗癌症的其他策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号